IN2012DN05209A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN05209A IN2012DN05209A IN5209DEN2012A IN2012DN05209A IN 2012DN05209 A IN2012DN05209 A IN 2012DN05209A IN 5209DEN2012 A IN5209DEN2012 A IN 5209DEN2012A IN 2012DN05209 A IN2012DN05209 A IN 2012DN05209A
- Authority
- IN
- India
- Prior art keywords
- crystalline form
- bimatoprost
- new
- date
- designated
- Prior art date
Links
- AQOKCDNYWBIDND-FTOWTWDKSA-N bimatoprost Chemical compound CCNC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1\C=C\[C@@H](O)CCC1=CC=CC=C1 AQOKCDNYWBIDND-FTOWTWDKSA-N 0.000 abstract 3
- 229960002470 bimatoprost Drugs 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/35—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/39—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26347109P | 2009-11-23 | 2009-11-23 | |
| PCT/US2010/057494 WO2011063276A1 (en) | 2009-11-23 | 2010-11-19 | 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)- cyclopentyl]-n-ethyl-hept-5-enamide (bimatoprost) in crystalline form ii, methods for preparation, and methods for use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN05209A true IN2012DN05209A (enExample) | 2015-10-23 |
Family
ID=43639099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5209DEN2012 IN2012DN05209A (enExample) | 2009-11-23 | 2010-11-19 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US8629185B2 (enExample) |
| EP (1) | EP2504313A1 (enExample) |
| JP (2) | JP5921439B2 (enExample) |
| KR (1) | KR20120085330A (enExample) |
| CN (2) | CN102712584B (enExample) |
| AU (1) | AU2010321831B2 (enExample) |
| BR (1) | BR112012012387A2 (enExample) |
| CA (1) | CA2781698A1 (enExample) |
| CL (1) | CL2012001339A1 (enExample) |
| CO (1) | CO6551754A2 (enExample) |
| HK (1) | HK1207570A1 (enExample) |
| IL (2) | IL219959A (enExample) |
| IN (1) | IN2012DN05209A (enExample) |
| MX (1) | MX2012005968A (enExample) |
| NZ (1) | NZ600263A (enExample) |
| PH (1) | PH12012501098A1 (enExample) |
| RU (1) | RU2577546C2 (enExample) |
| UA (1) | UA110696C2 (enExample) |
| WO (1) | WO2011063276A1 (enExample) |
| ZA (1) | ZA201203883B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012012387A2 (pt) * | 2009-11-23 | 2019-09-24 | Allergan Inc | 7-[3,5-di-hidroxi-5-fenil-pent-1-enil)-ciclopentil]-n-etil-hept-5-enamida (bimatoprost) na forma cristalina ii, métodos para a preparação e métodos de utilização da mesma |
| CN103649047B (zh) * | 2011-06-02 | 2017-01-11 | 奇诺因私人有限公司 | 用于制备前列腺素酰胺的方法 |
| SI2911623T1 (sl) | 2012-10-26 | 2019-12-31 | Forsight Vision5, Inc. | Oftalmični sistem za podaljšano sproščanje zdravila v oko |
| MX391620B (es) * | 2012-12-19 | 2025-03-19 | Novartis Ag | Formulaciones del inhibidor del antígeno-1 asociado a la función de linfocitos (lfa-1). |
| US9447014B2 (en) | 2012-12-28 | 2016-09-20 | Allergan, Inc. | Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof |
| US9120738B2 (en) | 2012-12-28 | 2015-09-01 | Allergan, Inc. | Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof |
| US10273206B2 (en) | 2014-06-27 | 2019-04-30 | Allergan, Inc. | Tromethamine salt of bimatoprost acid in crystalline form 1, methods for preparation, and methods for use thereof |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| CN115677549A (zh) * | 2022-10-27 | 2023-02-03 | 神隆医药（常熟）有限公司 | 一种贝美前列素手性异构体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7166730B2 (en) * | 2000-01-27 | 2007-01-23 | Fine Tech Laboratories, Ltd | Process for the preparation of prostaglandin derivatives |
| IL143477A (en) * | 2001-05-31 | 2009-07-20 | Finetech Pharmaceutical Ltd | Process for the preparation of 17-phenyl-18,19,20-trinor-pgf2?? and its derivatives |
| JP2004518612A (ja) * | 2000-07-28 | 2004-06-24 | インスパイアー ファーマシューティカルズ，インコーポレイティド | インドール誘導体を用いて眼圧を下降させる方法 |
| ATE407967T1 (de) * | 2003-12-30 | 2008-09-15 | Metabolix Inc | Nukleierungsmittel |
| IL177762A0 (en) * | 2006-08-29 | 2006-12-31 | Arieh Gutman | Bimatoprost crystalline form i |
| BR112012012387A2 (pt) * | 2009-11-23 | 2019-09-24 | Allergan Inc | 7-[3,5-di-hidroxi-5-fenil-pent-1-enil)-ciclopentil]-n-etil-hept-5-enamida (bimatoprost) na forma cristalina ii, métodos para a preparação e métodos de utilização da mesma |
-
2010
- 2010-11-19 BR BR112012012387A patent/BR112012012387A2/pt not_active IP Right Cessation
- 2010-11-19 PH PH1/2012/501098A patent/PH12012501098A1/en unknown
- 2010-11-19 EP EP10785274A patent/EP2504313A1/en not_active Ceased
- 2010-11-19 WO PCT/US2010/057494 patent/WO2011063276A1/en not_active Ceased
- 2010-11-19 UA UAA201207505A patent/UA110696C2/uk unknown
- 2010-11-19 JP JP2012541130A patent/JP5921439B2/ja not_active Expired - Fee Related
- 2010-11-19 MX MX2012005968A patent/MX2012005968A/es not_active Application Discontinuation
- 2010-11-19 CN CN201080062129.5A patent/CN102712584B/zh active Active
- 2010-11-19 RU RU2012125185/04A patent/RU2577546C2/ru active
- 2010-11-19 IN IN5209DEN2012 patent/IN2012DN05209A/en unknown
- 2010-11-19 NZ NZ600263A patent/NZ600263A/en unknown
- 2010-11-19 AU AU2010321831A patent/AU2010321831B2/en active Active
- 2010-11-19 CA CA2781698A patent/CA2781698A1/en not_active Abandoned
- 2010-11-19 CN CN201410542159.6A patent/CN104367580A/zh active Pending
- 2010-11-19 KR KR1020127016191A patent/KR20120085330A/ko not_active Ceased
- 2010-11-22 US US12/951,780 patent/US8629185B2/en active Active
-
2012
- 2012-05-23 CL CL2012001339A patent/CL2012001339A1/es unknown
- 2012-05-23 IL IL219959A patent/IL219959A/en active IP Right Grant
- 2012-05-28 ZA ZA2012/03883A patent/ZA201203883B/en unknown
- 2012-06-22 CO CO12104940A patent/CO6551754A2/es unknown
-
2013
- 2013-12-20 US US14/136,323 patent/US9181176B2/en active Active
-
2015
- 2015-07-12 IL IL239892A patent/IL239892A0/en unknown
- 2015-08-25 HK HK15108218.2A patent/HK1207570A1/xx unknown
-
2016
- 2016-02-05 JP JP2016021287A patent/JP2016094471A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN102712584A (zh) | 2012-10-03 |
| CL2012001339A1 (es) | 2012-08-10 |
| US20140113974A1 (en) | 2014-04-24 |
| IL239892A0 (en) | 2015-08-31 |
| CN102712584B (zh) | 2014-10-29 |
| JP2013511573A (ja) | 2013-04-04 |
| NZ600263A (en) | 2014-08-29 |
| AU2010321831B2 (en) | 2016-07-07 |
| RU2577546C2 (ru) | 2016-03-20 |
| US8629185B2 (en) | 2014-01-14 |
| CA2781698A1 (en) | 2011-05-26 |
| KR20120085330A (ko) | 2012-07-31 |
| ZA201203883B (en) | 2013-01-31 |
| IL219959A (en) | 2015-07-30 |
| PH12012501098A1 (en) | 2014-10-14 |
| US20110152376A1 (en) | 2011-06-23 |
| IL219959A0 (en) | 2012-07-31 |
| UA110696C2 (uk) | 2016-02-10 |
| RU2012125185A (ru) | 2013-12-27 |
| JP5921439B2 (ja) | 2016-05-24 |
| WO2011063276A1 (en) | 2011-05-26 |
| BR112012012387A2 (pt) | 2019-09-24 |
| JP2016094471A (ja) | 2016-05-26 |
| CN104367580A (zh) | 2015-02-25 |
| HK1207570A1 (en) | 2016-02-05 |
| EP2504313A1 (en) | 2012-10-03 |
| AU2010321831A1 (en) | 2012-06-21 |
| MX2012005968A (es) | 2012-08-15 |
| CO6551754A2 (es) | 2012-10-31 |
| US9181176B2 (en) | 2015-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN05209A (enExample) | ||
| IN2012DN02751A (enExample) | ||
| JOP20180102A1 (ar) | مركب صيدلاني | |
| GEP20156266B (en) | Spiroheterocyclic n-oxypiperidines as pesticides | |
| UA116809C2 (uk) | Застосування агрохімічних сумішей для збільшення життєздатності рослини | |
| MX348325B (es) | Composicion que contiene galacto-oligosacarido y un metodo para producirla. | |
| MX2014002625A (es) | Nuevas composiciones para la produccion de poliamidas coladas. | |
| MX2010004546A (es) | Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina. | |
| MY149154A (en) | Novel microbiocides | |
| MX346980B (es) | Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona. | |
| MX2009012309A (es) | El uso de hidrofobicos como aditivos en la cristalizacion de solidos. | |
| SA114350792B1 (ar) | شكل متبلر جديد من ملح الـبيميرولاست | |
| MX2011011059A (es) | Uso de propineb como repelente de aves. | |
| MX2012010443A (es) | Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos. | |
| TW200728310A (en) | Process for the preparation of ferri-succinylcasein | |
| IN2012DN03104A (enExample) | ||
| UA102816C2 (ru) | Способ синтеза кристаллической формы v агомелатина | |
| MX376203B (es) | Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-ciclopropanos. | |
| IN2014DN03245A (enExample) | ||
| MX342311B (es) | Nuevos compuestos de azaespirodecanona como inhibidores de lipasa sensible a hormonas (hsl). | |
| IN2012DN02000A (enExample) | ||
| MX2010003056A (es) | Polimorfos de valomaciclovir. | |
| EA201400606A1 (ru) | Полиолефиновое волокно | |
| MX2013013021A (es) | Nuevos compuestos de hexahidropirroloimidazolona. | |
| WO2014060575A3 (en) | Process for the enantioselective synthesis of a tetrahydrobenzazepine compound |